T1	chemical 101 111	metal-free
T2	disease_or_phenotypic_feature 126 129	air
T3	chemical 165 171	oxygen
T4	disease_or_phenotypic_feature 217 228	sensitivity
T5	corrected_chemical 607 635	immune checkpoint inhibitors
T6	chemical 625 635	inhibitors
T7	disease_or_phenotypic_feature 715 721	SCCHN.
T8	disease_or_phenotypic_feature 766 775	pituitary
T9	disease_or_phenotypic_feature 823 832	pituitary
T10	chemical 885 893	hormonal
T11	chemical 1017 1028	metabolites
T12	disease_or_phenotypic_feature 1105 1109	ASD.
T13	chemical 1135 1151	thyroid hormones
T14	chemical 1143 1151	hormones
T15	chemical 1156 1165	prolactin
T16	corrected_disease_or_phenotypic_feature 1229 1249	major mood disorders
T17	disease_or_phenotypic_feature 1240 1249	disorders
T18	corrected_disease_or_phenotypic_feature 1254 1273	psychotic disorders
T19	disease_or_phenotypic_feature 1264 1273	disorders
T20	chemical 1322 1339	calcium-phosphate
T21	disease_or_phenotypic_feature 1404 1418	oral mucositis
T22	chemical 1473 1480	protein
T23	disease_or_phenotypic_feature 1506 1512	common
T24	missed_chemical 1579 1597	immunosuppressants
T25	corrected_chemical 1648 1669	5-aminosalicylic acid
T26	chemical 1665 1669	acid
T27	corrected_disease_or_phenotypic_feature 1705 1728	opportunistic infection
T28	disease_or_phenotypic_feature 1719 1728	infection
T29	chemical 1814 1819	ozone
T30	disease_or_phenotypic_feature 1828 1834	injury
T31	chemical 1988 1994	sodium
T32	chemical 1995 2006	thiosulfate
T33	disease_or_phenotypic_feature 2007 2011	(STS
T34	disease_or_phenotypic_feature 2173 2181	epilepsy
T35	chemical 2222 2225	MES
T36	chemical 2368 2373	 veno
T37	chemical 2398 2405	 protei
T38	disease_or_phenotypic_feature 2443 2449	 cance
T39	disease_or_phenotypic_feature 2581 2599	pulmonary fibrosis
T40	chemical 2654 2662	molecule
T41	chemical 2663 2673	inhibitors
T42	chemical 2760 2768	androgen
T43	disease_or_phenotypic_feature 2806 2809	PCa
T44	chemical 3025 3032	nucleus
T45	disease_or_phenotypic_feature 3036 3043	HFD-fed
T46	disease_or_phenotypic_feature 3168 3174	cancer
T47	chemical 3191 3195	drug
T48	chemical 3298 3306	afatinib
T49	corrected_disease_or_phenotypic_feature 3320 3371	stage IV oligometastatic adenocarcinoma of the lung
T50	disease_or_phenotypic_feature 3345 3371	adenocarcinoma of the lung
T51	chemical 3447 3452	group
T52	disease_or_phenotypic_feature 3500 3517	esophageal cancer
T53	chemical 3542 3547	Lipid
T54	chemical 3559 3571	Anti-oxidant
T55	chemical 3591 3600	Gastrodin
T56	corrected_disease_or_phenotypic_feature 3604 3636	Nonalcoholic Fatty Liver Disease
T57	chemical 3617 3622	Fatty
T58	disease_or_phenotypic_feature 3617 3636	Fatty Liver Disease
T59	chemical 3727 3730	AOP
T60	disease_or_phenotypic_feature 3727 3730	AOP
R1	treats Arg1:T13 Arg2:T18
R2	treats Arg1:T13 Arg2:T16
R3	treats Arg1:T47 Arg2:T46
R4	treats Arg1:T20 Arg2:T21
R5	treats Arg1:T55 Arg2:T56
R6	FIXME Arg1:T5 Arg2:T7
R8	treats Arg1:T48 Arg2:T49
R9	treats Arg1:T48 Arg2:T50
R10	treats Arg1:T15 Arg2:T16
R11	treats Arg1:T15 Arg2:T18
R12	causes_or_contributes_to Arg1:T24 Arg2:T27
T61	corrected_disease_or_phenotypic_feature 715 720	SCCHN
R13	treats Arg1:T5 Arg2:T61	
R15	causes_or_contributes_to Arg1:T25 Arg2:T27	
T63	corrected_disease_or_phenotypic_feature 1814 1834	ozone induced injury
R16	causes_or_contributes_to Arg1:T29 Arg2:T63	
